Magnachip (MX) Q1 2026 earnings review

Sequential Stabilization, But Structural Turnaround Remains Distant

Magnachip delivered a sequential revenue and margin rebound in Q1 2026, signaling that the worst of the Q4 2025 inventory and pricing shocks may be over. Revenue of $46.2M beat the guidance midpoint, growing 13.9% QoQ and 3.3% YoY. However, earnings quality remains poor. Gross margin of 15.6%, while Reversing upward from Q4's disastrous 9.3%, is still down severely from 20.9% a year ago. The company is burning cash to fund an aggressive R&D pivot, leaving the balance sheet lighter. Q2 2026 guidance projects flat sequential revenue, indicating that the multi-year transformation will require significant patience from investors.

๐Ÿ‚ Bull Case

Inventory Headwinds Clearing

The sequential revenue growth (+13.9%) and margin recovery (+6.3 percentage points QoQ) suggest the harsh channel destocking and one-time incentives deployed in late 2025 have cleared the way for normalized order patterns.

New Product Cycle is Live

After launching 55 new-generation products in 2025, the pipeline is contributing to revenue. The successful release of 8th-generation BatteryFETs and MV MOSFETs proves R&D execution is on track.

๐Ÿป Bear Case

Structurally Depressed Margins

Despite the QoQ improvement, gross margins are down 5.3 percentage points YoY. Intense pricing pressure on legacy products, particularly in China, is capping profitability.

Shrinking Cash Buffer

Cash dropped by $9.2M in a single quarter to $94.5M. If new higher-margin products take too long to offset legacy pricing declines, liquidity could become a structural concern.

โš–๏ธ Verdict: ๐Ÿ”ด

Bearish. The QoQ stabilization prevents a disaster, but the YoY degradation in margins and the uninspiring Q2 guidance confirm the turnaround will be long and expensive. The Power IC segment's contraction adds further risk.

Key Themes

CONCERN๐Ÿ”ด

Persistent Macro Pricing Pressure in Legacy Portfolio

While gross margin improved sequentially to 15.6%, it remains down sharply from 20.9% in 25Q1. Management previously cited intense pricing pressure in China on older-generation products as a massive headwind. This data confirms the pressure is Decelerating but has not reversed. Until new products dilute the legacy mix, pricing will suppress margins.

CONCERNNEW๐Ÿ”ด

Power IC (PIC) Segment Contraction

The PIC segment is severely lagging the rest of the company. Revenue reversed to a contraction, dropping 6.2% YoY to $4.56M. Worse, PIC gross margin collapsed by 6.1 percentage points YoY to 40.4%. If this higher-margin segment continues to decay, achieving the long-term '3-3-3' corporate goal (30% total gross margin) becomes mathematically improbable.

DRIVER๐ŸŸข

New Product Acceleration Beginning to Scale

Magnachip is aggressively pushing its product roadmap to replace low-margin legacy revenue. Following 55 new product launches in 2025, Q1 26 saw the release of 8th-generation ultra low-Rss(on) 12V BatteryFETs for smartphones and 40V/60V MV MOSFETs for servers. The company is on track to launch another 55 products in 2026. This R&D velocity is the primary driver for eventual margin expansion.

DRIVERNEW๐ŸŸข

Power Analog Solutions (PAS) Rebounding

PAS revenue grew 13.1% sequentially and 4.5% YoY to $41.6M. Given PAS represents 90% of total revenue, its stabilization is vital. The QoQ growth indicates that the painful inventory corrections and $2.5M incentive programs from 2025 have effectively cleared the channel, allowing factory utilization to slowly recover.

CONCERNNEWโšช

Cash Burn Accelerating Amid Transformation

While Operating Cash Flow was positive at $1.5M, total cash and equivalents dropped by $9.2M QoQ to $94.5M. This was driven by $3.9M in CapEx, $3.7M in hedge collateral payments, and ongoing debt servicing. The cash runway remains Stable, but continuous drawdowns limit flexibility if the large ag/legacy turnaround is delayed.

Other KPIs

Adjusted EBITDA-$3.64 million

Reversing QoQ from -$8.85M in Q4 2025, but representing a Decelerating trend YoY (down from -$1.2M in Q1 2025). The improvement vs last quarter was driven entirely by higher sales volume and lack of one-time inventory charges, while R&D expenses remained elevated to support the new product launch schedule.

Capital Expenditures (CapEx)$3.9 million

Accelerating YoY from $0.2M in Q1 2025. This reflects the ongoing investments required to upgrade the Gumi Fab to handle the incoming wave of new-generation power products, though it is a drag on free cash flow in the near term.

SG&A Expenses$7.6 million

Decelerating YoY from $9.2M in Q1 2025 and down sequentially from $8.6M. This demonstrates that management's previously announced structural cost reduction and voluntary resignation programs are successfully taking root and providing a partial buffer to margin degradation.

Guidance

Q2 2026 Consolidated Revenue$44.5 - $48.5 million

Decelerating. The midpoint of $46.5M implies roughly flat sequential growth (+0.6%) and a YoY decline of 2.3% (vs $47.6M in 25Q2). This suggests that while the Q1 rebound stopped the bleeding, true top-line acceleration remains elusive.

Q2 2026 Gross Profit Margin17.0% - 19.0%

Reversing sequentially but Decelerating YoY. The 18.0% midpoint is a 240 basis point improvement over Q1 2026, reflecting better factory utilization and product mix. However, it remains below the 20.4% achieved in Q2 2025, confirming the persistent drag of China pricing pressure on legacy lines.

Key Questions

Power IC (PIC) Weakness

The PIC segment revenue declined 6.2% YoY and margins contracted by over 600 basis points. Is this a structural market share loss, or a temporary timing issue with specific customer rollouts?

Cash Burn Trajectory

With the cash balance dropping below $100M this quarter due to CapEx and hedge collateral, what is the absolute minimum cash threshold management feels comfortable operating with before seeking additional financing?

Pricing Pressure in Legacy Portfolio

You guided Q2 gross margins to 17-19%. Does this assume any stabilization in legacy product pricing in China, or are you assuming further deterioration offset by a higher mix of new 8th-generation products?

Silicon Carbide (SiC) Commercialization

Management previously discussed a thoughtful entry into the Silicon Carbide market. What specific engineering milestones were achieved in Q1, and has the timeline for initial revenue realization shifted?